A SIMPLE KEY FOR PSILOCYBIN UNVEILED

There will inevitably be some velocity bumps, largely due to psilocybin’s present-day classification for a Routine 1 drug. In Nov. 2022, the U.S. nonprofit Multidisciplinary Affiliation for Psychedelic Scientific studies (MAPS) declared that it experienced finished a 2nd phase-three demo on MDMA like a treatment for PTSD—a move greatly noticed